Myriad Genetics Inc
MYGN
ISIN null / Valor 338449
Myriad Genetics Inc
UMushroom community rating:
About company
Myriad Genetics Inc. is a company focused on providing high-quality healthcare services and products, with a particular emphasis on genetic testing and personalized medicine. The company's leadership team includes individuals with extensive experience in the healthcare industry, such as Paul J. Diaz, who has a background in managing Fortune 500 healthcare companies. Myriad Genetics also has a strong focus on technology, with individuals like Kevin R. Haas, who has a background in bioinformatics and molecular simulation. Mark Verratti, the chief commercial officer, is responsible for driving enterprise growth and enhancing commercial and marketing capabilities, particularly in the area of mental health services. Overall, Myriad Genetics is dedicated to leveraging technology and innovation to improve healthcare outcomes for patients.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
312 M
Market cap (USD)
1,440,870
Daily traded volume (Shares)
13.81 / 13.04
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
